Clinical Trial Update: GH and Cardiovascular Risk Factors [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on growth hormone and cardiovascular risk factors; the Amsterdam UMC study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Growth Hormone Deficiency
• Metabolic Syndrome

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Growth Hormone Deficiency, Cardiovascular Diseases | Phase 4 | Status: COMPLETED